Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687035 · ClinicalTrials.gov registry record · NA
PARTNER II Trial: S3iCAP
A NA study of Aortic Stenosis, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 1,822
- Enrollment target
- 20
- Study locations
NCT02687035: Completed NA study of Aortic Stenosis, sponsored by Edwards Lifesciences.
NCT02687035 is a NA study of Aortic Stenosis that has completed, run by Edwards Lifesciences. The registered enrollment target is 1,822 participants, above the 1,292-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (41% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02687035, a NA study of Aortic Stenosis, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,822 participants
- Enrollment target
- 20
- Study locations
Study Summary
Following completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis who were at intermediate surgical risk.
Primary Outcome
Number of deaths
Conditions Studied
Interventions
- DEVICE SAPIEN S3 valve
Study Locations (20)
California
- Scripps Green Hospital - La Jolla
- Cedars-Sinai Medical Center - Los Angeles
- Stanford Hospital and Clinics - Palo Alto
- Mercy General Hospital - Sacramento
Illinois
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- NorthShore University HealthSystem Research Institute - Evanston
- Prairie Education and Research Cooperative - Springfield
Florida
- Morton Plant Hospital - Clearwater
- University of Florida - Gainesville
Indiana
- Indiana University Health-Methodist Hospital - Indianapolis
- St. Vincent Medical Group, Inc./ St. Vincent Heart Center of Indiana, LLC - Indianapolis
Maryland
- MedStar Union Memorial Hospital - Baltimore
- University of Maryland Medical Center - Baltimore
Colorado
- University of Colorado Hospital - Denver
District of Columbia
- Washington Hospital Center DC - Washington D.C.
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,822 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02687035 record still lists
NCT02687035 is an interventional study that assigns participants to a tested intervention. Its 1,822 participants enrollment target places it among the larger protocols in the corpus, above the 1,292-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which SAPIEN S3 valve is the first listed.
NCT02687035 names 20 study sites across 11 states, led by California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT02687035 about?
NCT02687035 is a clinical study titled "PARTNER II Trial: S3iCAP". Following completion of enrollment in the PARTNER II SAPIEN 3 intermediate risk trial, this trial provided continued access to treatment for subjects with severe aortic stenosis who were at intermediate surgical risk.
What is the current status of trial NCT02687035?
This trial is currently completed. It is a NA study. The enrollment target is 1,822 participants. The study started on 2015-01. Estimated completion is 2018-12.
What conditions does trial NCT02687035 study?
This clinical trial studies the following conditions: Aortic Stenosis.
What interventions are being tested in trial NCT02687035?
The interventions under investigation include: SAPIEN S3 valve (DEVICE).
Who is sponsoring clinical trial NCT02687035?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02687035 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02687035's enrollment target sits among peer trials
1,822 6th of 26 higher than 21 of 26 other Aortic Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
RECRUITING · NA
-
PARTNER 3 Trial - Aortic Valve-in-Valve
RECRUITING · NA
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
RECRUITING · NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia